SUPAR AND OSTEOPONTIN CIRCULATING LEVELS IN LUPUS NEPHRITIS: ARE THEY EARLY MARKERS OF PODOCYTE DAMAGE

被引：0
|
作者：
Quaglia, Marco [1 ]
Musetti, Claudio [1 ]
Clemente, Nausicaa [2 ]
Chiocchetti, Annalisa [2 ]
Dianzani, Umberto [2 ]
Stratta, Piero [1 ]
机构：
[1] Univ Piemonte Orientale, Dept Translat Med Nephrol & Kidney Transplant, Novara, Italy
[2] Univ Piemonte Orientale, Dept Hlth Sci, Immunol Lab, Novara, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv188.81
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP118
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Myocardial Expression and Circulating Serum Levels of the Extracellular Matrix Markers MMP-2, MMP-9 and Osteopontin in Patients with Advanced Heart Failure Undergoing Ventricular Assist Device Placement
    Singh, Parvati
    Chokshi, Aalap
    Cheema, Faisal H.
    Khawaja, Tuba
    Chew, Michael
    Khan, Raffay S.
    Yu, Shuiqing
    Pak, Sang-Woo
    Takayama, Hiroo
    Naka, Yoshifumi
    Uriel, Nir
    Jorde, Ulrich P.
    Mancini, Donna
    Schulze, Paul C.
    CIRCULATION, 2010, 122 (21)
  • [42] Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV
    Hanaoka, Hironari
    Kaneko, Yuko
    Kuwana, Masataka
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2015, 25 (05) : 714 - 718
  • [43] ANTI-RITUXIMAB ANTIBODIES DEMONSTRATE NEUTRALISING CAPACITY, ASSOCIATE WITH LOWER CIRCULATING DRUG LEVELS AND EARLY RELAPSE IN PATIENTS UNDERGOING TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Wincup, C.
    Dunn, N.
    Ruetsch-Chelli, C.
    Manouchehrinia, A.
    Kharlamova, N.
    Naja, M.
    Seitz-Polski, B.
    Isenberg, D.
    Fogdell-Hahn, A.
    Ciurtin, C.
    Jury, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1344 - 1345
  • [44] ANTI-RITUXIMAB ANTIBODIES DEMONSTRATE NEUTRALISING CAPACITY, ASSOCIATE WITH LOWER CIRCULATING DRUG LEVELS AND EARLY RELAPSE IN PATIENTS UNDERGOING TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Wincup, Chris
    Dunn, Nicky
    Ruetsch-Chelli, Caroline
    Manouchehrinia, Ali
    Kharlamova, Nastya
    Naja, Meena
    Seitz-Polski, Barbara
    Isenberg, David
    Fogdell-Hahn, Anna
    Ciurtin, Coziana
    Jury, Elizabeth
    RHEUMATOLOGY, 2022, 61
  • [45] Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer's disease
    Gouilly, Dominique
    Vrillon, Agathe
    Bertrand, Elsa
    Goubeaud, Marie
    Catala, Helene
    Germain, Johanne
    Ainaoui, Nadera
    Rafiq, Marie
    Nogueira, Leonor
    Mouton-Liger, Francois
    Planton, Melanie
    Salabert, Anne-Sophie
    Hitzel, Anne
    Meligne, Deborah
    Jasse, Laurence
    Sarton, Benjamine
    Silva, Stein
    Lemesle, Beatrice
    Peran, Patrice
    Payoux, Pierre
    Thalamas, Claire
    Paquet, Claire
    Pariente, Jeremie
    NEUROIMAGE-CLINICAL, 2024, 43
  • [46] Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis -: The COBRA Study
    Garnero, P
    Landewé, R
    Boers, M
    Verhoeven, A
    van der Linden, S
    Christgau, S
    van der Heijde, D
    Boonen, A
    Geusens, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (11): : 2847 - 2856
  • [47] Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis
    Oestergaard, Svetlana
    Chouinard, Luc
    Doyle, Nancy
    Smith, Susan Y.
    Tanko, Laszlo B.
    Qvist, Per
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2886 - 2890
  • [48] HIGH-DOSE METHYLPREDNISOLONE (MP) PULSES INHIBIT INTERLEUKIN-6 (IL-6) SYNTHESIS IN CIRCULATING MONOCYTES BUT DO NOT INFLUENCE ENHANCED IL-6 URINARY LEVELS IN PATIENTS WITH LUPUS-NEPHRITIS
    CASIRAGHI, F
    GOTTI, E
    NORIS, M
    BENIGNI, A
    REMUZZI, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 348 - 348
  • [49] Despite lower levels of disease activity, late-onset lupus patients accrue more damage and experience increased mortality than patients with early-onset lupus:: Data from a large multiethnic cohort.
    Bertoli, AM
    Fernández, M
    Vilá, LM
    Fessler, BJ
    Bastian, HM
    Reveille, JD
    Alarcón, GS
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S184 - S184
  • [50] High circulating levels of CD62E+ and CD31+/Annexin V+ endothelium-derived microparticles in children with overweight/obesity: Evidence of early vascular damage
    Thomazini, Fernanda
    de Souza, Livia Victorino
    Prado, Monica Simon
    Agudelo, Juan Sebastian Henao
    de Almeida, Danilo Candido
    Franco, Maria do Carmo
    OBESITY RESEARCH & CLINICAL PRACTICE, 2022, 16 (02) : 115 - 121
12345